StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Earnings

Cryo-Cell International's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q3 FY2024
$8.07M
EPS, Q3 FY2024
$0.13
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Cryo-Cell International's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2024ended Aug 31, 2024Oct 17, 2024after the close$8.07M–$0.13Release
Q4 FY2021ended Nov 30, 2021Feb 24, 2022after the close–––Release
Q3 FY2021ended Aug 31, 2021Oct 15, 2021after the close$7.50M–$0.10Release
Q2 FY2021ended May 31, 2021Jul 19, 2021after the close–––Filing
Q1 FY2021ended Feb 28, 2021Apr 16, 2021after the close–––Filing
Q4 FY2020ended Nov 30, 2020Feb 25, 2021after the close–––Filing
Q3 FY2020ended Aug 31, 2020Oct 19, 2020after the close–––Filing
Q2 FY2020ended May 31, 2020Jul 13, 2020after the close–––Filing
Q1 FY2020ended Feb 29, 2020Mar 2, 2020after the close–––Filing
Q3 FY2019ended Aug 31, 2019Oct 17, 2019after the close–––Filing
Q2 FY2019ended May 31, 2019Jul 25, 2019after the close–––Filing
Q1 FY2019ended Feb 28, 2019Apr 16, 2019after the close–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Cryo-Cell International has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Cryo-Cell International puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Cryo-Cell International filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?